Related Experiment Videos

Loss of RhoB expression in human lung cancer progression

Julien Mazieres1, Teresita Antonia, Ghislaine Daste

  • 1Institut National de la Santé et de la Recherche Médicale U563, Department of Therapeutic Innovation and Molecular Oncology. Claudius Regaud Institute, Toulouse, France.

Abstract

Insights

Loss of RhoB protein expression is frequent in lung cancer, indicating its role as a tumor suppressor. Restoring RhoB may offer a new therapeutic strategy for lung cancer patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • GTPase Signaling

Background:

  • RhoB, a member of the Ras superfamily of low molecular weight GTPases, exhibits diverse cellular functions.
  • While many Rho proteins promote proliferation and malignancy, RhoB has been previously shown to inhibit cancer cell growth.

Purpose of the Study:

  • To investigate the specific role of RhoB in human lung cancer development and progression.
  • To determine if RhoB acts as a tumor suppressor in lung carcinogenesis.

Main Methods:

  • Immunohistochemical analysis of RhoB protein expression in 139 human lung tissue samples (94 + 45) across normal to invasive carcinoma stages.
  • Functional studies involving RhoB overexpression in the A549 lung cancer cell line and assessment of tumorigenicity in nude mice.

Main Results:

  • RhoB expression significantly decreased with lung cancer progression, with loss in 96% of invasive tumors and 86% in poorly differentiated tumors.
  • Loss of RhoB expression correlated with advanced tumor stage and higher proliferative index.
  • Ectopic RhoB expression suppressed lung cancer cell proliferation, anchorage-independent growth, and xenograft tumor formation in vivo.

Conclusions:

  • Frequent loss of RhoB expression in lung carcinogenesis supports its role as a tumor suppressor.
  • RhoB's tumor-suppressive activity suggests its potential as a therapeutic target for lung cancer treatment.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...